✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Gennex Laboratories Ltd.

GENNEX

Market Cap
₹260 Cr.
P/E
12.41

Gennex Laboratories Ltd.

  • Gennex Laboratories
  • Lyka Labs
  • Ambalal Sarabhai Ent

FAQs on Gennex Laboratories Ltd. Shareprice

Gennex Laboratories has given lower returns compared to its competitors.
Gennex Laboratories has grown at ~16.37% over the last 3yrs while peers have grown at a median rate of 18.76%

Gennex Laboratories is not expensive.
Latest PE of Gennex Laboratories is 12.41, while 3 year average PE is 28.28.
Also latest EV/EBITDA of Gennex Laboratories is 8.99 while 3yr average is 18.24.

View FAQ's On Business

Growth Table

  • Gennex Laboratories Ltd.
  • Lyka Labs
  • Ambalal Sarabhai Ent

Balance Sheet

  • Gennex Laboratories Ltd.
  • Lyka Labs
  • Ambalal Sarabhai Ent

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Gennex Laboratories Ltd.
  • Lyka Labs
  • Ambalal Sarabhai Ent

Cash Flow

  • Gennex Laboratories Ltd.
  • Lyka Labs
  • Ambalal Sarabhai Ent

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Gennex Laboratories Ltd.
  • Lyka Labs
  • Ambalal Sarabhai Ent

Quarterly Results

  • Gennex Laboratories Ltd.
  • Lyka Labs
  • Ambalal Sarabhai Ent

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Gennex Laboratories Ltd. Financials

Balance sheet of Gennex Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Gennex Laboratories is increasing.
Latest net debt of Gennex Laboratories is -₹16.46 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹86.31 Crs.

Yes, profit is increasing.
The profit of Gennex Laboratories is ₹20.98 Crs for TTM, ₹18.12 Crs for Mar 2025 and ₹11.37 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Gennex Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech